WARREN & ERIE, Pa.--(BUSINESS WIRE)--NewBridge Medical Research™ with offices located in Warren and Erie today announced it is recruiting patients with foot ulcers due to diabetes to participate in the MATRIX clinical trial. The trial will study the effects of a new product, Excellarate, for the potential treatment of patients with non-healing diabetic foot ulcers. Excellarate is an investigative product designed to stimulate the process of wound healing.
